2,6-二-O-甲基-β-环糊精结构式
|
常用名 | 2,6-二-O-甲基-β-环糊精 | 英文名 | Heptakis(2,6-di-O-methyl)-b-cyclodextrin |
---|---|---|---|---|
CAS号 | 51166-71-3 | 分子量 | 1331.356 | |
密度 | 1.4±0.1 g/cm3 | 沸点 | 1203.6±65.0 °C at 760 mmHg | |
分子式 | C56H98O35 | 熔点 | 298 - 310ºC | |
MSDS | 中文版 美版 | 闪点 | 681.7±34.3 °C |
2,6-二-O-甲基-β-环糊精用途2,6-二-O-甲基-β-环糊精是一种生物化学试剂,可作为生物材料或有机化合物进行生命科学相关研究。 |
中文名 | 二甲基环糊精 |
---|---|
英文名 | 2,6-di-o-methyl-beta-cyclodextrin |
中文别名 | 2,6-二-O-甲基-β-环糊精 | 二甲基-bata-环糊精 | 甲基-β-环糊精 | 七(2,6-二-O-甲基)-β-环糊精 | 2,6-二甲氧基-β-环糊精 |
英文别名 | 更多 |
密度 | 1.4±0.1 g/cm3 |
---|---|
沸点 | 1203.6±65.0 °C at 760 mmHg |
熔点 | 298 - 310ºC |
分子式 | C56H98O35 |
分子量 | 1331.356 |
闪点 | 681.7±34.3 °C |
精确质量 | 1330.588867 |
PSA | 400.05000 |
LogP | 6.96 |
外观性状 | 白色粉末 |
蒸汽压 | 0.0±0.6 mmHg at 25°C |
折射率 | 1.553 |
储存条件 | 保持贮藏器密封、储存在阴凉、干燥的地方,确保工作间有良好的通风或排气装置 |
稳定性 | 如果遵照规格使用和储存则不会分解,未有已知危险反应 |
水溶解性 | H2O: soluble |
计算化学 | 1.疏水参数计算参考值(XlogP):-7.5 2.氢键供体数量:7 3.氢键受体数量:35 4.可旋转化学键数量:21 5.互变异构体数量:无 6.拓扑分子极性表面积400 7.重原子数量:91 8.表面电荷:0 9.复杂度:1690 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:35 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
更多 | 1. 性状:粉末 2. 密度(g/mL,25ºC):未确定 3. 相对蒸汽密度(g/mL,空气=1): 未确定 4. 熔点(ºC):298-310 5. 沸点(ºC):未确定 6. 沸点(ºC,2mm hg):未确定 7. 折射率:163 8. 闪点(°C):未确定 9. 比旋光度(ºC):未确定 10. 自燃点或引燃温度(ºC): 未确定 11. 蒸气压(kPa,20ºC):未确定 12. 饱和蒸气压(kPa,60ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:能溶于水的 |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
安全声明 (欧洲) | 24/25 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | GU2293500 |
海关编码 | 29400090 |
2,6-二-O-甲基-β-环糊精上游产品 7 | |
---|---|
2,6-二-O-甲基-β-环糊精下游产品 1 | |
Evaluation of the separation mechanism of electrokinetic chromatography with a microemulsion and cyclodextrins using NMR and molecular modeling.
Electrophoresis 32(21) , 3062-9, (2011) Electrokinetic chromatography (EKC) allows the separation of closely related substances by the detection of fine effects in analyte-separation system interactions. With the goal of understanding the f... |
|
Synthesis, cytotoxicity, and phase-solubility study of cyclodextrin click clusters.
J. Pharm. Sci. 103(10) , 3183-9, (2014) To explore the possibility of cyclodextrin click clusters (CCCs) as a new cyclodextrin-based excipient, we prepared three different CCCs; heptakis{6-(4-hydroxymethyl-1H-[1,2,3]triazol-1-yl)-6-deoxy}-β... |
|
Host-guest interaction between new nitrooxoisoaporphine and β-cyclodextrins: synthesis, electrochemical, electron spin resonance and molecular modeling studies.
Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 102 , 226-34, (2013) A new nitrooxoisoaporphine derivative was synthetized and characterized by cyclic voltammetry and electron spin resonance. Its aqueous solubility was improved by complexes formation with β-cyclodextri... |
Dimethyl-beta-cyclodextrin,methylated beta-cyclodextrins |
2,6-Di-O-methyl-β-cyclodextrin |
Dimethyl β-cyclodextrin |
Heptakis(2,6-di-O-methyl)-b-cyclodextrin |
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36S,37R,38S,39R,40S,41R,42S,43R,44S,45R,46S,47R,48S,49R)-37,39,41,43,45,47,49-Heptamethoxy-5,10,15,20,25,30,35-heptakis( ;methoxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.2.2.2.2.2.2]nonatetracontane-36,38,40,42,44,46,48-heptol |
MFCD00011616 |
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36S,37R,38S,39R,40S,41R,42S,43R,44S,45R,46S,47R,48S,49R)-37,39,41,43,45,47,49-Heptamethoxy-5,10,15,20,25,30,35-heptakis(methoxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.2.2.2.2.2.2]nonatetracontane-36,38,40,42,44,46,48-heptol (non-preferred name) |